Valiant Organics Limited · NSE:VALIANTORG
Valiant Organics — Q2 FY2025 Earnings Presentation
24 slides from Valiant Organics's earnings presentation, Dec 3, 2024
Slide 1: Exchange filing cover letter for investor presentation
December 03, 2024 To, To, Listing / Compliance Department Listing / Compliance Department BSE LTD National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block Bandra-Kurla, Complex, Bandra (E), Mumbai- 400 001. Mumbai- 400 051. CODE-540145
Slide 2: Earnings Presentation | Q2/H1-FY25
Earnings Presentation | Q2/H1 -FY25
Slide 3: Snapshot
SNAPSHOT One of the largest chlorophenol One of the leading manufacturer of derivatives manufacturer globally Benzene derivatives products One of the largest domestic PNA One of the few commercial players in manufacturer Ortho Anisidine and Para Anisidine Diversified client base across Amongst 1st f
Slide 4: Company Overview
Company Overview Valiant Organics Limited was incorporated in 1984 by first generation technocrats and is headquartered out of Mumbai, India. The company is focused on the manufacturing and marketing of specialty chemicals which find usage in a variety of industries, including agrochemicals, pharmac
Slide 5: Chemistries And Product Basket
Chemistries And Product Basket H1-FY25 Revenue Share Hydrogenation Ammonolysis 43% Key Products: Industries Served: Key Products: • Ortho Anisidine Industries Served: • Dyes • Para Nitro Aniline • Para Anisidine • Dyes • Pigments • Ortho Chloro Para Nitro Aniline • IPPCA • Pigments • Pharmaceutical
Slide 6: Manufacturing Footprint
Manufacturing Footprint CHLORINATION – SARIGAM HYDROGENATION & METHOXYLATION- • Capacity: 18,000 MTPA JHAGADIA UNIT 1 • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, • Capacity: 27,000 MTPA 2,4,6 TCP • Products: ONA/OA, PNA/PA, IPPCA, CONVERSION PRODUCTS AMMONOLYSIS - VAPI HYDROGENATION – JHAGADIA UNIT 2 •
Slide 7: Key Strengths
Key Strengths Domain expertise and broad Plant locations are process understanding in a Wide supply chain strategically located near variety of chemistries. The provides the continuous ports to provide a executive team is made up of availability of adequate competitive advantage, first-generation te
Slide 8: Q2/H1-FY25 Highlights
Q2/H1-FY25 HIGHLIGHTS Valiant Organics Limited | Q2-2025 7
Slide 9: Consolidated Financial Highlights
CONSOLIDATED FINANCIAL HIGHLIGHTS Q2-FY25 CONSOLIDATED FINANCIAL HIGHLIGHTS H1-FY25 CONSOLIDATED FINANCIAL HIGHLIGHTS INR 1,602 Mn INR 3,281 Mn Operational Revenue Operational Revenue INR 24 Mn INR 182 Mn Operating EBITDA Operating EBITDA 1.50% 5.55% Operating EBITDA Margin Operating EBITDA Margin I
Slide 10: Q2/H1-FY25 Operational Highlights
Q2/H1-FY25 Operational Highlights Q2-FY25 Revenue Break-up – Chemistries • There was an overall 6% decline in sales volume in Q2-FY25. Others, 7% • The quarter saw decreased demand in Agrochemicals, Dyes & Pigments segment, Chlorination, significantly influencing overall performance negatively. 17%
Slide 11: Key Chemistries: Revenues and Sales Volumes
Key Chemistries Chlorination (INR Mn) Hydrogenation (INR Mn) Ammonolysis (INR Mn) Others (INR Mn) 1000 894 560 543 140 136 359 900 730 400 327 REVENUES 135 800 660 540 350 300 274 700 520 130 250 600 500 500 125 200 400 500 479 120 118 118 150 480 300 115 100 200 460 110 50 100 440 105 0 0 Q2-FY24 Q
Slide 12: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance Particulars (INR Mn) Q2-FY25 Q2-FY24 Y-o-Y Q1-FY25 Q-o-Q Revenue from Operations 1,602 2,031 (21.1)% 1,679 (4.6)% Total Expenses 1,578 1,876 (15.9)% 1,522 3.7% EBITDA 24 155 (84.5)% 157 (84.7)% EBITDA Margins (%) 1.5% 7.63% (613) Bps 9.35% (785) Bps Other
Slide 13: YTD Consolidated Financial Performance
YTD Consolidated Financial Performance Particulars (INR Mn) H1-FY25 H1-FY24 Y-o-Y Revenue from Operations 3,281 4,049 (19.0)% Total Expenses 3,099 3,655 (15.2)% EBITDA 182 394 (53.8)% EBITDA Margins (%) 5.55% 9.73% (418) Bps Other Income 29 68 (57.4)% Depreciation 176 176 NA Finance Cost 132 81 63.0
Slide 14: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance Particulars (INR Mn) Q2-FY25 Q2-FY24 Y-o-Y Q1-FY25 Q-o-Q Revenue from Operations 1,602 1,825 (12.2)% 1,679 (4.6)% Total Expenses 1,579 1,652 (4.4)% 1,522 3.7% EBITDA 23 173 (86.7)% 157 (85.4)% EBITDA Margins (%) 1.44% 9.48% (804) Bps 9.35% (791) Bps Other I
Slide 15: YTD Standalone Financial Performance
YTD Standalone Financial Performance Particulars (INR Mn) H1-FY25 H1-FY24 Y-o-Y Revenue from Operations 3,281 3,591 (8.6)% Total Expenses 3,099 3,216 (3.6)% EBITDA 182 375 (51.5)% EBITDA Margins (%) 5.55% 10.44% (489) Bps Other Income 24 5 NA Depreciation 176 166 6.0% Finance Cost 132 81 63.0% Profi
Slide 16: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW Valiant Organics Limited | Q2-2025 15
Slide 17: Historical Consolidated Income Statement
Historical Consolidated Income Statement Particulars (INR Mn) FY22 FY23 FY24 H1-FY25 Revenue from Operations 11,533 10,518 7,231 3,281 Total Expenses 9,484 8,875 6,849 3,099 EBITDA 2,049 1,643 382 182 EBITDA Margins (%) 17.77% 15.62% 5.28% 5.55% Other Income 74 80 93 29 Depreciation 296 292 349 176
Slide 18: Consolidated Balance Sheet
Consolidated Balance Sheet Particulars (INR Mn) FY23 FY24 H1-FY25 Particulars (INR Mn) FY23 FY24 H1-FY25 EQUITY 7,401 7,293 7,166 Non-Current Assets 7,682 8,352 8,305 a) Equity Share Capital 272 276 276 a) Property, Plant and Equipment 6,565 6,297 6,239 b) Other Equity 6,616 7,017 6,887 c) Right-Of-
Slide 19: Historical Standalone Income Statement
Historical Standalone Income Statement Particulars (INR Mn) FY22 FY23 FY24 H1-FY25 Revenue from Operations 9,484 9,116 6,772 3,281 Total Expenses 7,811 7,817 6,376 3,099 EBITDA 1,673 1,299 396 182 EBITDA Margins (%) 17.64% 14.25% 5.85% 5.55% Other Income 33 29 29 24 Depreciation 273 276 340 176 Fina
Slide 20: Standalone Balance Sheet
Standalone Balance Sheet Particulars (INR Mn) FY23 FY24 H1-FY25 Particulars (INR Mn) FY23 FY24 H1-FY25 EQUITY 6,661 6,649 6,537 Non-Current Assets 7,424 7,818 7,790 a) Equity Share Capital 272 276 276 a) Property, Plant and Equipment 6,092 6,297 6,239 b) Other Equity 6,385 6,373 6,261 b) Right-Of-Us
Slide 21: Consolidated Financial Highlights
Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) & EBITDA Margins (%) PAT (INR Mn) & PAT Margins (%) 11,533 1,400 1,279 10,518 2,049 10,000 1,643 1,100 1,026 7,500 7,231 800 5,000 500 3,281 17.77% 15.62% 382 182 11.09% 9.75% 2,500 200 5.28% -84 -131 5.55% - -100 FY22 FY
Slide 22: Capital Market Information
Capital Market Information Share Price up to 30th Sept, 2024 50% 30% 10% -10% -30% -50% -70% Oct-23 Nov-23 Dec-23 Jan-24 Feb-24 Mar-24 Apr-24 May-24 Jun-24 Jul-24 Aug-24 Sep-24 Valiant Organics Sensex Shareholding pattern (As on 30th Sept, 2024) Price Data (As on 30th Sept, 2024) INR FII; 1.33% DII;
Slide 23: Disclaimer
Disclaimer Valiant Organics Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all event
Slide 24: Thank You
THANK YOU Valiant Organics Limited | Q2-2025 23